Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Congenital Hyperinsulinism
NCT02524639Phase 2Withdrawn
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Aug 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in congenital hyperinsulinism (HI), sponsored by Children's Hospital of Philadelphia. Planned start Aug 2015; status: withdrawn.
02
Drugs
sirolimus
03
Conditions
congenital hyperinsulinism (HI)
Beyond the preview
Go deeper on NCT02524639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02524639.